We make precision medicine technology simple and affordable at point of care, powered by comprehensive clinical decision support technology services and tools for providers. MiGenesys™ pharmacogenetic tests give insights to physicians on how a patient's DNA affects their response to drugs and assist the physician with personalizing the drug selection and dose adjustment to improve medication therapy safety and efficacy.
MiGenesys Pharmacogenetic (PGx) test analyzes a patient’s DNA to determine how he or she may respond to certain medications. This information can help providers make better prescription decisions, protect patients from adverse drug reactions and drug ineffectiveness, and reduce healthcare costs.
MiGenesys™ cardiovascular test provides pharmacogenetic insights in to routinely prescribed drug classes used in cardiology, including anti-platelet, anti-coagulant, statins, beta-blockers, ACE inhibitors, calcium channel blockers and hormone therapies.
MiGenesys™ Neurology test provides pharmacogenetic insights in to routinely prescribed drug classes used in Neurology.
MiGenesys™ General practice test provides pharmacogenetic insights in to commonly prescribed medicines by general practitioners.
MiGenesys™ Pain test provides pharmacogenetic insights in to opioids, non-steroidal anti-inflammatory drugs, and other pain drugs.
MiGenesys™ Gastroenterology test provides pharmacogenetic insights in to acid reducers including proton pump inhibitors.
MiGenesys™ Psychiatry test provides pharmacogenetic insights in to routinely prescribed drug classes used in psychiatry including selective serotonin reuptake inhibitors, or SSRI, serotonin-norepinephrine reuptake inhibitors, or SNRI, and tricyclic antidepressants as well as antipsychotic drugs.
MiGenesys is partnering with premier hospitals, clinics, labs, and healthcare organizations around the world who are committed to bringing latest advances in healthcare technology into patient care and provide personalized treatment options for patients.